Ranocor ER 500 mg (Tablet (Extended Release))
Unit Price: ৳ 16.00 (3 x 10: ৳ 480.00)
Strip Price: ৳ 160.00
Medicine Details
Category | Details |
---|---|
Generic | Ranolazine |
Company | Popular pharmaceuticals ltd |
Indications
- Treatment of chronic angina
- May be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowering therapy, ACE inhibitors, and angiotensin receptor blockers
- Decreases angina episodes in patients with coronary artery disease
- Effects on angina rate or exercise tolerance may vary in women and men
Pharmacology
- Anti-ischemic effects
- Anti-anginal effects
- Inhibition of cardiac late sodium current (I_Na)
- Prolongs the QT interval
- Inhibition of I_Kr
- Absorption: C_max - 2-5 h
- Half-life: 6-22 h
- Approximately 62% bound to human plasma proteins
- Metabolized mainly by CYP3A and to a lesser extent by CYP2D6
- Metabolized rapidly and extensively in the liver and intestine
- Excreted in urine and feces
Dosage & Administration
- Initial dose of 500 mg twice daily
- Maximum recommended daily dose of 1000 mg twice daily
- Swallow whole, do not crush, break or chew
- Pediatric use not established
Interaction
- Avoid use with strong CYP 3A inhibitors
- Limit maximum dose with moderate CYP 3A inhibitors
- Adjust dosage with P-gp Inhibitors (e.g., Cyclosporin)
- May require reduced doses of drugs transported by P-gp or metabolized by CYP2D6 when used together
Contraindications
- Pre-existing QT prolongation
- Hepatic impairment
- Taking QT prolonging drugs
- Taking potent and moderately potent CYP3A inhibitors
Side Effects
- Bradycardia
- Palpitations
- Tinnitus
- Vertigo
- Abdominal pain
- Dry mouth
- Vomiting
- Peripheral edema
- Dyspnea
- Hypotension
- Orthostatic hypotension
Pregnancy & Lactation
- Category C - potential risk to the fetus
- Use during pregnancy when benefit justifies risk
- Not known whether excreted in human milk
- Consider discontinuing nursing or drug, taking into account importance to the mother
Precautions & Warnings
- Blocks QTc and prolongs the QTc interval
- Experience in acute coronary syndrome population did not show increased risk of proarrhythmia or sudden death
- Increased plasma concentrations of digoxin when co-administered
- Caution with co-administration with P-gp inhibitors like ritonavir or cyclosporine
Overdose Effects
- Dose-related increases in dizziness, nausea, and vomiting
- Produces diplopia, paresthesia, confusion, and syncope with high intravenous exposure
- Continuous ECG monitoring may be warranted
- Unlikely to be cleared by hemodialysis
Therapeutic Class
- Other Anti-anginal & Anti-ischaemic drugs
Storage Conditions
- Keep below 30°C temperature
- Away from light & moisture
- Keep out of the reach of children
Related Brands
- Ralozine SR 500 mg (Tablet (Sustained Release)) - incepta-pharmaceuticals-ltd
- Ranolin XR 500 mg (Tablet (Extended Release)) - square-pharmaceuticals-plc
- Ranola 500 mg (Tablet (Extended Release)) - general-pharmaceuticals-ltd
- Ranozex 500 mg (Tablet (Extended Release)) - sun-pharmaceutical-bangladesh-ltd
- Antogin ER 500 mg (Tablet (Extended Release)) - renata-limited